GLIDAPAFLOZIN TRIO 1 FORTE 

Dapagliflozin , glimepiride & metformin Hydrochloride ( extended Release )

Introduction

GLIDAPAFLOZIN TRIO 1 FORTE is a combination medication that includes Dapagliflozin, Glimepiride, and Metformin Hydrochloride (Extended Release). This medication is specifically designed to manage type 2 diabetes mellitus by addressing various pathways involved in glucose regulation. Each component of this combination plays a unique role in enhancing glycemic control, making it an effective treatment option for patients who require multiple medications to achieve optimal blood sugar levels.

Uses

GLIDAPAFLOZIN TRIO 1 FORTE is indicated for the treatment of type 2 diabetes mellitus. Its key uses include:

• Enhanced Glycemic Control: By combining Dapagliflozin, Glimepiride, and Metformin, this medication helps to lower blood glucose levels through different mechanisms. Dapagliflozin inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, promoting glucose excretion. Glimepiride stimulates insulin secretion from the pancreas, and Metformin decreases hepatic glucose production and increases insulin sensitivity.
• Reduction of HbA1c Levels: Regular use of this combination can significantly reduce glycated hemoglobin (HbA1c) levels, a crucial marker for long-term glucose control.
• Weight Management: Dapagliflozin and Metformin contribute to weight management, an important aspect of diabetes care.
• Cardiovascular Benefits: Dapagliflozin has been shown to provide cardiovascular benefits, reducing the risk of heart failure in diabetic patients.

Dosage

The appropriate dosage of GLIDAPAFLOZIN TRIO 1 FORTE should be determined by a healthcare provider based on individual needs and response to treatment. General dosage guidelines are as follows:

• Initial Dose: Typically, one tablet is taken once daily with a meal to reduce gastrointestinal side effects. It is important to take the medication at the same time each day to maintain consistent blood levels.
• Adjustment: Depending on the patient’s response and glycemic control, the healthcare provider may adjust the dosage. Regular monitoring of blood glucose levels is necessary to determine the effectiveness of the medication and make any required adjustments.

It is crucial to follow the prescribed dosage and not exceed the recommended amount. Periodic HbA1c tests and daily blood glucose monitoring are recommended to assess the treatment's effectiveness.

Side Effects

While GLIDAPAFLOZIN TRIO 1 FORTE is generally well-tolerated, some individuals may experience side effects. Common and less common side effects include:

• Common Side Effects:

  • Gastrointestinal Issues: Nausea, diarrhea, and abdominal discomfort are common due to Metformin.
  • Hypoglycemia: Glimepiride can cause low blood sugar levels, leading to symptoms such as dizziness, sweating, and confusion.
  • Genital Infections: Dapagliflozin can increase the risk of genital infections due to increased glucose excretion.
  • Urinary Tract Infections: Increased glucose in the urine can lead to a higher risk of urinary tract infections.

• Less Common Side Effects:

  • Allergic Reactions: Rash, itching, and swelling may occur. Severe reactions require immediate medical attention.
  • Lactic Acidosis: A rare but serious side effect of Metformin that necessitates immediate medical intervention. Symptoms include muscle pain, difficulty breathing, and severe fatigue.
  • Dehydration: Dapagliflozin can cause dehydration due to increased urination. Patients should ensure adequate fluid intake.

If any side effects are severe or persistent, it is essential to consult a healthcare provider promptly. Regular monitoring and communication with the healthcare provider are vital to managing any potential side effects effectively.

Price

The price of GLIDAPAFLOZIN TRIO 1 FORTE can vary depending on the region, pharmacy, and any applicable insurance coverage. Generally, it is competitively priced within the range of combination medications for diabetes. For the most accurate pricing, it is advisable to check with local pharmacies or online retailers.

Conclusion

GLIDAPAFLOZIN TRIO 1 FORTE, with its combination of Dapagliflozin, Glimepiride, and Metformin Hydrochloride (Extended Release), offers a powerful solution for managing type 2 diabetes mellitus. Its multi-faceted approach helps achieve better glycemic control, reduce HbA1c levels, and manage weight effectively. While it provides significant benefits, users should be aware of potential side effects and discuss them with their healthcare provider to ensure the therapy is safe and effective. Regular monitoring and adherence to prescribed dosages are crucial for achieving the best outcomes with GLIDAPAFLOZIN TRIO 1 FORTE. Always consult with a healthcare provider before starting any new medication to ensure it is appropriate for your specific condition and to receive personalized dosage recommendations. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW